SciSparc Ltd. Ordinary Shares (SPRC)

Price$11.44

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-50.15%

Price vs S&P 500 (4W)83.05%

VGM Score55.64

Market Capitalization$6.56M

All Metrics

Book Value / Share (Quarterly)$104.38

P/TBV (Annual)1.45x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-14.09%

Cash Flow / Share (Quarterly)$-101.87

Price vs S&P 500 (YTD)-14.69%

Net Profit Margin (TTM)-1633.03%

EPS (TTM)$-461.25

10-Day Avg Trading Volume4.63M

EPS Excl Extra (TTM)$-461.25

EPS (Annual)$-299.98

ROI (Annual)-265.05%

Gross Margin (Annual)73.71%

Net Profit Margin (5Y Avg)-526.97%

Cash / Share (Quarterly)$113.05

ROA (Last FY)-159.79%

EBITD / Share (TTM)$-341.85

ROE (5Y Avg)-108.59%

Operating Margin (TTM)-1295.37%

Cash Flow / Share (Annual)$-101.87

P/B Ratio1.55x

P/B Ratio (Quarterly)1.05x

Net Income / Employee (Annual)$-6,089,500

Net Interest Coverage (TTM)-1.18x

ROA (TTM)-337.07%

EPS Incl Extra (Annual)$-299.98

Current Ratio (Annual)2.41x

Quick Ratio (Quarterly)2.38x

3-Month Avg Trading Volume0.80M

52-Week Price Return-80.97%

Revenue / Employee (TTM)$658,500

Tangible BV / Share (Quarterly)$75.57

P/S Ratio (Annual)7.66x

Asset Turnover (Annual)0.11x

52-Week High$80.10

Operating Margin (5Y Avg)-523.09%

EPS Excl Extra (Annual)$-299.98

Tangible BV CAGR (5Y)-27.06%

26-Week Price Return-42.22%

Quick Ratio (Annual)2.34x

13-Week Price Return105.76%

Total Debt / Equity (Annual)0.08x

Current Ratio (Quarterly)2.41x

Enterprise Value$2.32M

Asset Turnover (TTM)0.21x

Book Value / Share Growth (5Y)73.71%

Revenue / Employee (Annual)$428,000

Inventory Turnover (Annual)2.39x

Pretax Margin (Annual)-1467.76%

Cash / Share (Annual)$113.05

3-Month Return Std Dev322.26%

Net Income / Employee (TTM)$-10,753,500

ROE (Last FY)-287.31%

Net Interest Coverage (Annual)-3.47x

EPS Basic Excl Extra (Annual)$-299.98

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$-461.25

Receivables Turnover (Annual)85.60x

ROI (TTM)-265.05%

P/S Ratio (TTM)4.98x

Pretax Margin (5Y Avg)-559.36%

Revenue / Share (Annual)$21.08

Tangible BV / Share (Annual)$75.57

Price vs S&P 500 (52W)-105.34%

Year-to-Date Return-6.54%

5-Day Price Return8.03%

EPS Normalized (Annual)$-299.98

ROA (5Y Avg)-69.82%

Net Profit Margin (Annual)-1422.78%

Month-to-Date Return16.62%

Cash Flow / Share (TTM)$-1.11

EBITD / Share (Annual)$-200.49

Operating Margin (Annual)-978.27%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-103.77%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-461.25

P/TBV (Quarterly)1.45x

P/B Ratio (Annual)1.05x

Pretax Margin (TTM)-1668.64%

Book Value / Share (Annual)$104.38

Price vs S&P 500 (13W)97.50%

Beta2.33x

Revenue / Share (TTM)$32.44

ROE (TTM)-287.31%

52-Week Low$2.98

mGradeC

vgmGradeC

Show chart for

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
SPRCSciSparc Ltd. Ordinary Shares	—	—	C	$11.44
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

SciSparc Ltd is a clinical-stage biopharmaceutical company developing cannabinoid-based immunotherapy products and holds patents in the immunotherapy field. The company operates two segments: pharmaceutical development targeting regulatory approval, and e-commerce sales of hemp-derived consumer products including supplements and topical treatments manufactured in the United States.